Aiming to deliver the best quality ophthalmic care
We provide treatments for both Dry AMD and Dry Eyes.
Dry AMD (Age-Related Macular Degeneration) is a leading cause of poor central vision for people in their later years. As populations age, the global presence of AMD was predicted to increase by 20% between 2020 (about 196 million sufferers) and 2030 (243 million sufferers).
An increasing number of people worldwide suffer from dry eye disease (DED), the result of which can have a detrimental effect on vision, quality of life and work productivity. One in five, and nearly 800 million people worldwide, suffer from DED. Over 50% of females over the age of 40, and over 90% of menopausal females, are thought to live with this condition.
